The Accelerated Drug Approval

被引：12
|
作者：
Novack, Gary D.
机构：
来源：
OCULAR SURFACE | 2010年 / 8卷 / 04期
关键词：
CLINICAL-TRIAL DESIGN; END-POINTS SYMPOSIUM;
D O I：
10.1016/S1542-0124(12)70235-5
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [31] Anatomy of an FDA Drug Recall: The 17α-Hydroxyprogesterone Accelerated Approval and Withdrawal Processes
    Norwitz, Errol R.
    Norwitz, Gabriella A.
    Diaz, Angela M.
    Davis, Jonathan
    CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2024, 13 (03): : 171 - 179
  • [32] Balancing Accelerated Approval for Drugs With Accelerated Withdrawal
    Braillon, Alain
    Menkes, David B.
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 566 - 567
  • [33] Accelerated Approval Program Versus NCCN Guidelines as Mechanisms for Early Drug Access
    Wesevich, Austin
    Ratain, Mark J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (06): : 435 - 436
  • [34] Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug
    Mehta, Gautam U.
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (32)
  • [35] Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A Roadmap
    Landgren, Ola
    Devlin, Sean M.
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 13 - 22
  • [36] US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
    Omae, Kenji
    Onishi, Akira
    Sahker, Ethan
    Furukawa, Toshi A.
    JAMA NETWORK OPEN, 2022, 5 (09)
  • [37] Slowing down accelerated approval
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (03) : 165 - 165
  • [38] Accelerated approval requirements for lurbinectedin
    Benjamin, David J.
    Prasad, Vinay
    LANCET ONCOLOGY, 2022, 23 (05): : E206 - E206
  • [39] Accelerated Approval Is Not Conditional Approval Insights From International Expedited Approval Programs
    Mehta, Gautam U.
    de Claro, R. Angelo
    Pazdur, Richard
    JAMA ONCOLOGY, 2022, 8 (03) : 335 - 336
  • [40] Balancing Accelerated Approval for Drugs With Accelerated Withdrawal Reply
    Kim, Chul
    Prasad, Vinay
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 567 - 567
12345